Get all your news in one place.
100's of premium titles.
One app.
Start reading
Evening Standard
Evening Standard
World
Daniel Keane

Casgevy: World-first gene therapy for sickle cell disease approved in UK

The UK’s medical regulator on Thursday approved the world’s first gene therapy that aims to cure sickle cell disease.

Casgevy is the first medicine to be licensed that uses the gene-editing tool Crispr, for which its inventors were awarded the Nobel Prize in 2020.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.